Bernard J Zovighian Edwards Lifesciences Corp (EW) insider trading activity

Bernard J Zovighian is CEO of Edwards Lifesciences Corp. Currently has a direct ownership of 68,217 shares of EW, which is worth approximately $4.57 Million. The most recent transaction as insider was on May 30, 2024, when has been sold 8,617 shares (Common Stock) at a price of $87.68 per share, resulting in proceeds of $755,538. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.2K

0% 3M change

44.8% 12M change

Total Value Held $4.57 Million

Bernard J Zovighian Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 30 2024	SELL Open market or private sale	$755,538 $87.68 p/Share	8,617 Reduced 11.22%	68,217 Common Stock
May 11 2024	SELL Payment of exercise price or tax liability	$247,498 $86.72 p/Share	2,854 Reduced 3.58%	76,834 Common Stock
May 07 2024	SELL Payment of exercise price or tax liability	$55,053 $85.09 p/Share	647 Reduced 0.81%	79,688 Common Stock
May 07 2024	BUY Grant, award, or other acquisition	-	33,500 Added 29.43%	80,335 Common Stock
May 04 2024	SELL Payment of exercise price or tax liability	$316,959 $85.25 p/Share	3,718 Reduced 7.35%	46,835 Common Stock
May 04 2024	BUY Exercise of conversion of derivative security	-	6,265 Added 11.03%	50,553 Common Stock
May 03 2024	SELL Payment of exercise price or tax liability	$44,826 $85.06 p/Share	527 Reduced 1.18%	44,288 Common Stock
Jul 31 2023	BUY Discretionary transaction	$213,695 $83.54 p/Share	2,558 Added 5.15%	47,111 Common Stock
May 11 2023	BUY Grant, award, or other acquisition	-	22,525 Added 33.58%	44,552 Common Stock
May 08 2023	SELL Payment of exercise price or tax liability	$127,164 $88.74 p/Share	1,433 Reduced 6.11%	22,027 Common Stock
May 07 2023	SELL Payment of exercise price or tax liability	$206,143 $88.74 p/Share	2,323 Reduced 9.01%	23,460 Common Stock
May 07 2023	BUY Exercise of conversion of derivative security	-	5,003 Added 16.25%	25,783 Common Stock
May 04 2023	SELL Payment of exercise price or tax liability	$32,596 $88.1 p/Share	370 Reduced 1.75%	20,780 Common Stock
May 03 2023	SELL Payment of exercise price or tax liability	$31,523 $87.81 p/Share	359 Reduced 1.67%	21,150 Common Stock
Aug 05 2022	SELL Open market or private sale	$498,708 $103.66 p/Share	4,811 Reduced 18.46%	21,246 Common Stock
Jun 14 2022	SELL Open market or private sale	$421,990 $87.75 p/Share	4,809 Reduced 15.61%	26,007 Common Stock
May 31 2022	SELL Open market or private sale	$907,470 $100.83 p/Share	9,000 Reduced 22.6%	30,816 Common Stock
May 24 2022	SELL Open market or private sale	$459,356 $95.52 p/Share	4,809 Reduced 10.78%	39,816 Common Stock
May 17 2022	SELL Payment of exercise price or tax liability	$164,136 $95.93 p/Share	1,711 Reduced 3.69%	44,625 Common Stock
May 08 2022	SELL Payment of exercise price or tax liability	$687,255 $100.52 p/Share	6,837 Reduced 12.86%	46,336 Common Stock
May 08 2022	BUY Exercise of conversion of derivative security	-	12,600 Added 19.16%	53,173 Common Stock
May 07 2022	SELL Payment of exercise price or tax liability	$63,629 $100.52 p/Share	633 Reduced 1.54%	40,573 Common Stock
May 04 2022	SELL Payment of exercise price or tax liability	$39,194 $105.93 p/Share	370 Reduced 0.89%	41,206 Common Stock
May 03 2022	BUY Grant, award, or other acquisition	-	4,150 Added 9.08%	41,576 Common Stock

BJZ

Bernard J Zovighian

CEO

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account